Driving innovation
for Life Sciences in Europe

About EUCOPE

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ biopharmaceutical companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent.

Based in Brussels, Belgium, EUCOPE’s commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through ground-breaking therapies and medical technology. We provide a platform for discussion on major healthcare topics and developments, provide ad hoc expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard first in the early stages of policy-making and legislative procedures.

Read more…

Upcoming Events

28
Jan

28. January 2025 to 28. November 2024 — Register here

EU Health Summit 2025: Reshaping health for a stronger Europe

Healthy populations are essential for Europe to achieve its vision of a secure, competitive, and prosperous continent. Yet, European health systems are navigating a perfect storm: ageing populations, rising chronic diseases, and a health workforce under strain. European societies are facing combined cost-of-living, geopolitical, and… read more

25
Feb

25. February 2025 to 27. February 2025 — Register here

Bio-neuroscience

Bio-Neuroscience convenes innovators, CEOs and decision-makers in CNS neuroscience drug development from the leading biotech companies, investors and pharma companies in the sector. ​Investor and industry interest is booming, yet key challenges remain that can only be addressed by bringing together the leading translational research,… read more

5
Mar

5. March 2025 to 6. March 2025 — Register here

World EPA Congress 2025

The World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 300 speakers, multiple streams and over 1200 attendees from pharma, biotech and Payers/HTA’s. Join in Amsterdam for 2025! See here the agenda and speakers.

Our Events Section

News & Updates

EVENT RECAP – What Drives Life Sciences Investment in the EU and the Future Impact of the Pharma Package?

On November 14th, EUCOPE together with FTI Consulting EU hosted the event “What Drives Life Sciences Investment in the EU and the Future Impact of the Pharma Package”, to mark the launch of the report, ‘’The Economic Lens: Understanding What Makes the EU Attractive for… read more

Pharmaceutical innovators are concerned over not enough advice meetings being offered in 2025 for discussing trial designs and evidence generation plans, with serious ramifications on the ability to undergo Joint Clinical Assessments

ARM, EFPIA, EUCOPE, EuropaBio, Vaccines Europe From 12 January 2025 the Regulation (EU) 2021/2282 on health technology assessment will apply and the first Joint Clinical Assessments (JCA) will be performed to assess the relative clinical effectiveness of new innovative cancer therapies and cell and gene… read more

A New Drive For Competitiveness – EUCOPE Welcomes New European Commissioners

A new college of Commissioners All signs point towards the need for a more competitive environment for pharmaceutical R&D in Europe. In this context, EUCOPE extends its congratulations to the newly appointed European Commissioners, whose mandates will deliver on large-scale change initiated under the last… read more

EUCOPE Member Spotlight: Q&A with Bristol Myers Squibb

Regularly, EUCOPE spotlights a member company and the great work it’s doing to advance the life sciences industry and drive innovation to serve patients better. For the November edition, we spoke with Adam Parnaby, Senior Director, Market Access Policy, Europe, Bristol Myers Squibb. Tell us… read more

EUCOPE and FTI Consulting EU Unveil New Report on Life Sciences Investment in the EU

Brussels, 15 November 2023 Today, EUCOPE and FTI Consulting EU published a report titled The Economic Lens: Understanding What Makes the EU Attractive for Life Sciences Investments. The report provides an analysis of the current environment in the EU for attracting life sciences investments and… read more

2 new members join EUCOPE network in October 2024

The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of two new members at its quarterly Members Meeting on 16 October 2024, following Board approval. The new members joining the EUCOPE network are: Avidity Biosciences and Decisive Consulting. EUCOPE’s Secretary General Alexander Natz stated,… read more

Building a Competitive and Attractive Pharmaceutical Ecosystem in the EU

On Tuesday 24 September, Alexander Natz, Secretary General of the European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE), sent a letter to the President of the European Commission Ursula von der Leyen, President of the European Parliament Roberta Metsola, and President of the European Council Charles Michel,… read more

EVENT RECAP – Life Science Lectures – Episode eight – “The European Health Data Space (EHDS): your journey from regulation to implementation’’

On 2 September, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs hosted the eighth episode of its Life Science Lectures webinar series. The focus of the webinar, titled: ‘‘Implementing the European Health Data Space’’ was to delve into the implications of the secondary use of… read more

EUCOPE Member Spotlight: Q&A with EVERSANA

Every month, EUCOPE spotlights a member company and the great work it’s doing to advance the life sciences industry and drive innovation to serve patients better. This September, we spoke with Mike Ryan, Manager, Europe, EVERSANA. Mike Ryan has worked across the life sciences and… read more

EUCOPE congratulates Ursula von der Leyen on her second mandate as President of the European Commission

EUCOPE congratulates Ursula von der Leyen on the confirmation of her second term as President of the European Commission. Her leadership and commitment to public health have been instrumental in steering Europe through challenging times. It is now fundamental to build on these accomplishments, delivering… read more

... or browse news by Tag

Patients Rare Disease Medicines Regulatory Health innovation Access Members Research COVID19 Events Commission ATMPs podcast HTA OMP Medical Devices Digital EMA IVDR Job Posting Brexit genomics MDR EHDS AdvancedDxs European Parliament European Commission Safety HERA SoHO Regulation data act biotech PharmaPackage EU Health pharma GDPR Supply MEDTECH EU Beating Cancer Plan Genomic Testing Joint Statement EPSCO competitiveness EU Institutions

Our News Section

Interested in becoming a member?

EUCOPE gives voice to small to medium-sized innovative companies active in the field of pharmaceuticals, biotechnologies, and medical technologies at the European level. Learn more about the benefits of membership with EUCOPE.

Benefits of membership